Exploring the Role of Psychedelics in Modulating Ego and Treating Neuropsychiatric Disorders.
ACS Chemical Neuroscience May 7, 2025 DOI: 10.1021/acschemneuro.5c00247 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Viewpoint Peer reviewed |
|---|---|
| Topics | Default mode network LSD Psilocybin |
| Keywords | Ego Neuropsychiatric diseases Psychedelics hallucinogens Entheogens Mental health psychiatry Neuropsychiatry Mental illness Behavioral health |
| Citations | 5 |
| Key points | Psychedelics modulate brain entropy and ego dissolution to disrupt rigid neural patterns, offering therapeutic potential for neuropsychiatric disorders. |
Abstract
This viewpoint explores the therapeutic potential of psychedelics in treating neuropsychiatric disorders, particularly through the modulation of brain entropy and the experience of ego dissolution. Psychedelics disrupt rigid neural patterns, facilitating enhanced connectivity and fostering profound emotional breakthroughs that may alleviate symptoms of disorders like depression, anxiety, PTSD, and addiction. Despite their promising potential, the clinical application of psychedelics presents significant challenges, including the need for careful patient screening, managing adverse experiences, and addressing ethical considerations, all of which are essential for their safe integration into therapy.